NASDAQ: HOLX
Hologic, Inc.
Healthcare · Medical - Instruments & Supplies
Market Cap
$16.97B
52w High
$76.07
52w Low
$51.90
P/E
31.57
Volume
101.96M
Outstanding Shares
223.24M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 24.06% over the last year. Revenue grew 2.16% over the trailing twelve months. Operating margin moved from 23.45% to 17.49%. Free cash flow declined 9.56% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 17.49%. A decisive move in revenue — currently up 2.16% — would be the clearest signal to resolve the ambiguity.
Company profile
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions.
Valuation
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
18
Buy
23
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est $1.09 · Revenue est $1.03B
View